These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 26708281)
1. Uncertainty analysis in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) cancer dose-response for three occupational cohorts. Dong Z; Yuan G; Hu J Environ Int; 2016 Mar; 88():53-59. PubMed ID: 26708281 [TBL] [Abstract][Full Text] [Related]
2. Exposure reconstruction for the TCDD-exposed NIOSH cohort using a concentration- and age-dependent model of elimination. Aylward LL; Brunet RC; Starr TB; Carrier G; Delzell E; Cheng H; Beall C Risk Anal; 2005 Aug; 25(4):945-56. PubMed ID: 16268942 [TBL] [Abstract][Full Text] [Related]
3. Impact of physiologically based pharmacokinetic modeling on benchmark dose calculations for TCDD-induced biochemical responses. Kim AH; Kohn MC; Portier CJ; Walker NJ Regul Toxicol Pharmacol; 2002 Dec; 36(3):287-96. PubMed ID: 12473413 [TBL] [Abstract][Full Text] [Related]
4. On the translation of uncertainty from toxicokinetic to toxicodynamic models--the TCDD example. Heinzl H; Mittlböck M; Edler L Chemosphere; 2007 Apr; 67(9):S365-74. PubMed ID: 17224175 [TBL] [Abstract][Full Text] [Related]
5. Risk assessment for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) based on an epidemiologic study. Steenland K; Deddens J; Piacitelli L Am J Epidemiol; 2001 Sep; 154(5):451-8. PubMed ID: 11532787 [TBL] [Abstract][Full Text] [Related]
6. Use of a toxicokinetic model in the analysis of cancer mortality in relation to the estimated absorbed dose of dioxin (2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD). Salvan A; Thomaseth K; Bortot P; Sartori N Sci Total Environ; 2001 Jul; 274(1-3):21-35. PubMed ID: 11453298 [TBL] [Abstract][Full Text] [Related]
7. Concentration-dependent TCDD elimination kinetics in humans: toxicokinetic modeling for moderately to highly exposed adults from Seveso, Italy, and Vienna, Austria, and impact on dose estimates for the NIOSH cohort. Aylward LL; Brunet RC; Carrier G; Hays SM; Cushing CA; Needham LL; Patterson DG; Gerthoux PM; Brambilla P; Mocarelli P J Expo Anal Environ Epidemiol; 2005 Jan; 15(1):51-65. PubMed ID: 15083163 [TBL] [Abstract][Full Text] [Related]
8. An evaluation of benchmark dose methodology for non-cancer continuous-data health effects in animals due to exposures to dioxin (TCDD). Gaylor DW; Aylward LL Regul Toxicol Pharmacol; 2004 Aug; 40(1):9-17. PubMed ID: 15265602 [TBL] [Abstract][Full Text] [Related]
9. Modelling of 2,3,7,8-tetrachlorodibenzo-p-dioxin levels in a cohort of workers with exposure to phenoxy herbicides and chlorophenols. Heederik D; Hooiveld M; Bueno-de-Mesquita HB Chemosphere; 1998; 37(9-12):1743-54. PubMed ID: 9828302 [TBL] [Abstract][Full Text] [Related]
10. Basis for a proposed reference dose (RfD) for dioxin of 1-10 pg/kg-day: a weight of evidence evaluation of the human and animal studies. Greene JF; Hays S; Paustenbach D J Toxicol Environ Health B Crit Rev; 2003; 6(2):115-59. PubMed ID: 12554432 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the use of a physiologically based pharmacokinetic model and a classical pharmacokinetic model for dioxin exposure assessments. Emond C; Michalek JE; Birnbaum LS; DeVito MJ Environ Health Perspect; 2005 Dec; 113(12):1666-8. PubMed ID: 16330344 [TBL] [Abstract][Full Text] [Related]
14. Use of a physiologically based pharmacokinetic model for rats to study the influence of body fat mass and induction of CYP1A2 on the pharmacokinetics of TCDD. Emond C; Birnbaum LS; DeVito MJ Environ Health Perspect; 2006 Sep; 114(9):1394-400. PubMed ID: 16966094 [TBL] [Abstract][Full Text] [Related]
15. Physiologically based pharmacokinetic model for developmental exposures to TCDD in the rat. Emond C; Birnbaum LS; DeVito MJ Toxicol Sci; 2004 Jul; 80(1):115-33. PubMed ID: 15056810 [TBL] [Abstract][Full Text] [Related]
16. Estimation of occupational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin using a minimal physiologic toxicokinetic model. Thomaseth K; Salvan A Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):743-53. PubMed ID: 9599726 [TBL] [Abstract][Full Text] [Related]
17. Application of pharmacokinetic modelling for 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure assessment. Ruiz P; Aylward LL; Mumtaz M SAR QSAR Environ Res; 2014; 25(11):873-90. PubMed ID: 25397879 [TBL] [Abstract][Full Text] [Related]
18. Cutaneous elimination of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Geusau A; Tschachler E; Meixner M; Päpke O; Stingl G; McLachlan M Br J Dermatol; 2001 Dec; 145(6):938-43. PubMed ID: 11899147 [TBL] [Abstract][Full Text] [Related]
19. Physiologically based toxicokinetic models and in silico predicted partition coefficients to estimate tetrachlorodibenzo-p-dioxin transfer from feed into growing pigs. Savvateeva D; Numata J; Pieper R; Schafft H; Lahrssen-Wiederholt M; Bulik S Arch Toxicol; 2020 Jan; 94(1):187-196. PubMed ID: 31728592 [TBL] [Abstract][Full Text] [Related]
20. Olestra increases faecal excretion of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Geusau A; Tschachler E; Meixner M; Sandermann S; Päpke O; Wolf C; Valic E; Stingl G; McLachlan M Lancet; 1999 Oct; 354(9186):1266-7. PubMed ID: 10520643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]